Novavax, Inc. - Common Stock (NQ:NVAX)

12.39 +1.93 (+18.45%)

Delayed Quote Updated: 2:38 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

68 69 Next >

Jack Ma's Ant Group Slapped With $1B Fine, Carl Icahn's Huge Short Position In GameStop, Novavax Culls COVID-19 Vaccine Alliance With GAVI: Top Stories Tuesday, Nov. 22 ↗

November 22, 2022

Reuters

Via Benzinga

Novavax Terminates Agreement With GAVI Alliance For Sale Of Its COVID-19 Vaccines ↗

November 22, 2022

Novavax Inc (NASDAQ: NVAX) delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of its COVID-19 vaccine to low- and middle-income...

Via Benzinga

Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025 ↗

November 22, 2022

These beaten-down innovators have industry-changing potential.

Via The Motley Fool

What Is Going on With Novavax (NVAX) Stock Today? ↗

November 18, 2022

Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19.

Via InvestorPlace

Could This Bullish News Make Novavax a Hot Buy? ↗

October 27, 2022

Can this turn the stock's fortunes around?

Via The Motley Fool

Is It Too Late to Buy Novavax Stock? ↗

October 20, 2022

The company has been struggling lately.

Via The Motley Fool

Canada Approves Novavax's COVID-19 Vaccine As Booster In Adults ↗

November 18, 2022

Health Canada has granted expanded approval to Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (COVID-19 Vaccine as a homologous booster in adults aged 18 and older.

Via Benzinga

While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants

November 16, 2022

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END

Via FinancialNewsMedia

Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say ↗

November 15, 2022

Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler...

Via Benzinga

2 Cheap Stocks to Buy Right Now ↗

November 15, 2022

Both companies performed well during the worst of the pandemic, but things have changed since then.

Via The Motley Fool

Here Are All 23 Stocks I've Bought During the 2022 Bear Market ↗

November 13, 2022

A historically bad year for Wall Street is a gift for long-term investors with cash at the ready.

Via The Motley Fool

Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows ↗

November 11, 2022

Via Benzinga

Nasdaq Bear Market: 3 Phenomenal Bargains That Can Double Your Money by 2027 ↗

November 10, 2022

These amazing deals are ripe for the picking and poised to deliver triple-digit returns in five years.

Via The Motley Fool

Novavax Posts Unexpected Q3 Loss, But Revenue Surpass Expectations ↗

November 09, 2022

Novavax Inc (NASDAQ: NVAX) revised its FY22 sales forecast for the second time in three months amid waning demand for COVID-19 vaccines.

Via Benzinga

The Make-Or-Break Moment For Novavax: What To Watch In Third-Quarter Earnings ↗

November 08, 2022

Investors are looking for one key positive metric from Novavax's third-quarter earnings.

Via Investor's Business Daily

Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses ↗

November 08, 2022

Via Benzinga

Preview: Novavax's Earnings ↗

November 07, 2022

Novavax (NASDAQ:NVAX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Novavax will report...

Via Benzinga

7 Nasdaq Stocks Smart Investors Shouldn’t Touch With a 10-Foot Pole ↗

November 07, 2022

With macro forces changing the paradigm in the equities sector and the broader economy, it’s time to consider Nasdaq stocks to avoid.

Via InvestorPlace

Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends. ↗

November 01, 2022

As the Fed continues to tighten the market, consider putting these seven on your list of overvalued Nasdaq stocks to sell before 2022 ends.

Via InvestorPlace

9 Health Care Stocks Whale Activity In Today's Session ↗

November 01, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Avis Budget, Scholastic And Other Big Gainers From Monday ↗

October 25, 2022

U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Moderna, Amazon, Tesla, And Other Big Gainers From Friday ↗

October 24, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 750 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

Why Novavax Stock Rose 12.57% on Friday ↗

October 21, 2022

Investors did an about-face after the stock slumped earlier in the week.

Via The Motley Fool

Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today? ↗

October 21, 2022

Vaccine stocks are flying higher on Friday on word that Pfizer will quadruple the price of its Covid-19 vaccine. Will others follow suit?

Via InvestorPlace

Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

October 21, 2022

Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.

Via Benzinga

Twitter Rebuffs Elon Musk Layoff Plans Report, Toyota Cuts 2023's Production Target, Vaccine Makers Expect 3x Price Increase In COVID-19 Shot: Top Stories Friday, Oct. 21 ↗

October 21, 2022

Bloomberg

Via Benzinga

Jim Cramer Says This Stock 'Down Here At This Level Is A Terrific Buy' ↗

October 21, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is against Novavax (NASDAQ: NVAX).

Via Benzinga

Vaccine Makers Mull Price Increase For COVID-19 Boosters Amid Falling Demand ↗

October 21, 2022

Via Benzinga

Short Interest Sector Focus: Healthcare Sector ↗

October 20, 2022

As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.